| abstract |
Liquid pharmaceutical composition in the form of a concentrate for the preparation of an infusion solution, which contains, in particular, constituted by, alprostadil (prostaglandin E1) as active ingredient, dissolved in a pharmaceutically acceptable organic solvent or in a mixture of solvents less a pharmaceutically acceptable organic solvent and water, for use in the treatment of occlusive disease of the peripheral arteries (EOAP) by intra-arterial infusion (ia). |